Article
Sickle cell patient's journey leads to landmark approval of gene-editing treatment
Rating:
0.0
Views:
22
Likes:
1
Library:
1
In early December, the Food and Drug Administration approved a gene-editing treatment for sickle cell disease, the first for any illness. One patient helped pave the way.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value